Denali Therapeutics Inc. · NASDAQ:DNLI
Thornberry Nancy received 6,408 Denali Therapeutics Inc. shares as an award (Form 4)
Traded Jun 3, 2026 · Filed Jun 5, 2026
On Jun 3, 2026, Thornberry Nancy (Director) received 6,408 Denali Therapeutics Inc. shares as an award, leaving 31,125 shares. Filed Jun 5, 2026 (Form 4).
- Awarded
- 6,408 shares
- Holding after
- 31,125 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | Award | 6,408 | 31,125 | Direct |
Source
Related
- Denali Therapeutics Inc.
- Thornberry Nancy
- Denali Therapeutics Inc. shareholders
- Form 4 · Thornberry Nancy · Sep 4, 2026
- Form 4 · Chin Peter Scott · Sep 9, 2026
- Form 4 · Schuth Alexander O. · Sep 3, 2026
- Form 4 · Watts Ryan J. · Aug 14, 2026
- Form 4 · Schuth Alexander O. · Aug 13, 2026
- Schedule 13G/A · Baillie Gifford & Co · Aug 4, 2026